Tahira Iqbal

MINERAL COMPOSITION OF STRAWBERRY, MULBERRY AND CHERRY FRUITS AT DIFFERENT RIPENING STAGES AS ANALYZED BY INDUCTIVELY COUPLED PLASMA-OPTICAL EMISSION SPECTROSCOPY

Mineral contents of strawberry (Fragaria x ananassa), mulberry (Morus alba, M. nigra, M. macroura, and M. laevigata) and cherry (Prunus avium) fruits at un-ripened, semi-ripened and fully-ripened stages were investigated. The concentrations (mg kg−1) of potassium (K), phosphorus (P), calcium (Ca), and magnesium (Mg) in the fruits (DW), at fully-ripened stage, varied from 2600 (mulberry) to 3300 (strawberry), 1854 (cherry) to 2954 (mulberry), 1855 (cherry) to 4375 (mulberry) and 1025 (cherry) to 2225 (mulberry), respectively. Sizeable amounts (mg kg−1) of Zn 408 (strawberry) to 1110 (mulberry) and Fe 236 (cherry) to 1080 (mulberry) were also determined. Moreover, the tested fruits contained considerable amounts of sodium (Na), manganese (Mn), aluminum (Al), and copper (Cu). Overall, the concentrations of these minerals except K were found to decrease as fruit maturity progressed. The tested fruits, especially Morus species, can be explored as a rich source of Zn and Fe, the two essential elements that are in short supply in human diet.

Determination of in vitro antidiabetic effects of Zingiber officinale Roscoe

Aqueous extracts of Zingiber officinale rhizomes were studied to evaluate their antidiabetic effects on protein glycation and on the diffusion of glucose in vitro in the present study. Zingiber officinale rhizome aqueous extract were examined at concentrations of 5, 10, 20 and 40 g/L. The antidiabetic effects were found to be dose-dependent. Antidiabetic potential of Zingiber officinale was mainly through inhibition of the glucose diffusion and to a limited extent by reducing the glycation. However, further studies are needed to determine in vitro effects of therapeutic potential by restraining postprandial glucose absorptions and plasma protein glycations in diabetic subjects.

Effect of acetaminophen on sulfamethazine acetylation in male volunteers

The effect of acetaminophen on sulfamethazine N-acetylation by human N-acetyltrasferase-2 (NAT2) was studied in 19 (n = 19) healthy male volunteers in two different phases. In the first phase of the study the volunteers were given an oral dose of sulfamethazine 500 mg alone and blood and urine samples were collected. After the 10-day washout period the same selected volunteers were again administered sulfamethazine 500 mg along with 1000 mg acetaminophen. The acetylation of sulfamethazine by human NAT2 in both phases with and without acetaminophen was determined by HPLC to establish their respective phenotypes. In conclusion obtained statistics of present study revealed that acetaminophen significantly (P <0.0001) decreased sulfamethazine acetylation in plasma of both slow and fast acetylator male volunteers. A highly significant (P <0.0001) decrease in plasma-free and total sulfamethazine concentration was also observed when acetaminophen was co-administered. Urine acetylation status in both phases of the study was found not to be in complete concordance with that of plasma. Acetaminophen significantly (P <0.0001) increased the acetyl, free and total sulfamethazine concentration in urine of both slow and fast acetylators. Urine acetylation analysis has not been found to be a suitable approach for phenotypic studies.

Exclusion of Zn(II) from aqueous solution using corncob (Zea mays stalk) after chemical modifications with inorganic acids and bases

AbstractIn the conducted research, corncob powder was pretreated with inorganic acids and bases. The consequence of different parameters such as initial metal concentration, pH, and contact time on Zn(II) biosorption from aqueous solution was deliberated. The order of maximum Zn(II) uptake qmax (mg g−1) for different pretreated and raw corncob powder was Ba(OH)2 (128.9) > H3PO4 (124.07) > NaOH (118.737) > H2SO4 (114.8) > HCl (93.41) > Al(OH)3 (87.9) > Native (86.74). The percentage of Zn(II) removed on corncob biomass increased with increase in pH reaching a maximum at pH 5.5. Kinetics of Zn(II) biosorption described that Zn(II) sorption rate was high in first 15–30 min and equilibrium was established after 120 min. The maximum adsorption data of native and pretreated biomass was investigated using Langmuir, Freundlich equilibrium, and Pseudo-first and second-order kinetic models. It was accomplished that structural modifications onto corncob powder lead to the formation of novel biomasses with increased ...

Effect of UDP-Glucuronosyltransferase (UGT) 1A Polymorphism (rs8330 and rs10929303) on Glucuronidation Status of Acetaminophen:

Interindividual variability in polymorphic uridine diphosphate-glucuronosyltransferase 1A1 (UGT1A1) ascribed to genetic diversity is associated with relative glucuronidation level among individuals. The present research was aimed to study the effect of 2 important single nucleotide polymorphisms (SNPs; rs8330 and rs10929303) of UGT1A1 gene on glucuronidation status of acetaminophen in healthy volunteers (n = 109). Among enrolled volunteers, 54.13% were male (n = 59) and 45.87% were female (n = 50). The in vivo activity of UGT1A1 was investigated by high-performance liquid chromatography-based analysis of glucuronidation status (ie, acetaminophen and acetaminophen glucuronide) in human volunteers after oral intake of a single dose (1000 mg) of acetaminophen. The TaqMan SNP genotyping assay was used for UGT1A1 genotyping. The wild-type genotype (C/C) was observed the most frequent one for both SNPs (rs8330 and rs10929303) and associated with fast glucuronidator phenotypes. The distribution of variant genotype (G/G) for SNP rs8330 was observed in 5% of male and 8% of the female population; however, for SNP rs10929303, the G/G genotype was found in 8% of both genders. A trimodal distribution (fast, intermediate, and slow) based on phenotypes was observed. Among the male participants, the glucuronidation phenotypes were observed as 7% slow, 37% intermediate, and 56% fast glucuronidators; however, these findings for the females were slightly different as 8%, 32%, and 60% respectively. The k-statistics revealed a compelling evidence for good concordance between phenotype and genotype with a k value of 1.00 for SNP rs8330 and 0.966 for SNP rs10929303 in our population.

An expedient reverse‐phase high‐performance chromatography (RP‐HPLC) based method for high‐throughput analysis of deferoxamine and ferrioxamine in urine

The present study was planned to optimize and validate an expedient reverse-phase high chromatography (RP-HPLC) based protocol for the analysis of deferoxamine (DFO) and ferrioxamine (FO) in urinary execration of patients suffering β-thalassemia major. The optimized RP-HPLC method was found to be linear over the wide range of DFO and FO concentration (1-90 μg/mL) with appreciable recovery rates (79.64-97.30%) of quality controls at improved detection and quantitation limits and acceptable inter and intraday variability. Real-time analysis of DFO and FO in the urine of thalassemic patients (male and female) at different intervals of Desferal®(Novartis Pharmaceuticals Corporation) injection revealed DFO and FO excretion at significantly (p < 0) different rates. The maximum concentrations of DFO (76.7 ± 3.06 μg/mL) and FO (74.2 ± 3.25 μg/mL) were found in urine samples, collected after 6 h of drug infusion while the minimum levels of DFO (1.10 ± 0.12 μg/mL) and FO (2.97 ± 0.13 μg/mL) were excreted by patients after 24 h. The present paper offers balanced conditions for an expedient, reliable and quick determination of DFO and FO in urine samples.